# Sugammadex/Neostigmine and Liver Transplantation

> **NCT02697929** · NA · COMPLETED · sponsor: **Azienda Ospedaliera S. Maria della Misericordia** · enrollment: 40 (actual)

## Conditions studied

- Postoperative Residual Curarization
- Liver Transplantation

## Interventions

- **DRUG:** sugammadex
- **DRUG:** Neostigmine

## Key facts

- **NCT ID:** NCT02697929
- **Lead sponsor:** Azienda Ospedaliera S. Maria della Misericordia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02697929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02697929, "Sugammadex/Neostigmine and Liver Transplantation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02697929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*